It has been confirmed that the PD-1/PD-L1 axis is a classical immune suppressor in MS, and despite the regulation mechanisms of this axis throughout the MS course still being unknown, several studies have shown PD-L1 deficiency and a correlation with disease progression [70]. This evidence concerns the gene PDCD1 and myeloid sarcoma.